These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 7524905

  • 41. Recombinant human granulocyte-colony stimulating factor and recombinant human macrophage-colony stimulating factor synergize in vivo to enhance proliferation of granulocyte-macrophage, erythroid, and multipotential progenitor cells in mice.
    Broxmeyer HE, Williams DE, Cooper S, Hangoc G, Ralph P.
    J Cell Biochem; 1988 Oct; 38(2):127-36. PubMed ID: 2464604
    [Abstract] [Full Text] [Related]

  • 42. Circulation of progenitor cells after intensive chemotherapy followed by combination G-CSF and EPO in breast carcinoma.
    Filip S, Vanásek J, Bláha M, Vávrová J.
    Neoplasma; 1997 Oct; 44(4):212-8. PubMed ID: 9473775
    [Abstract] [Full Text] [Related]

  • 43. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S, Hicks M, Rosenthal H, Langston A, Redei I, Torre C, Duenzl M, Feinstein B, Cherry J, Waller EK.
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
    [Abstract] [Full Text] [Related]

  • 44. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M, Couture F, Kovacs M, Saragosa R, McCrae J, Brandwein J, Huebsch L, Beauregard-Zollinger L, Keating A.
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [Abstract] [Full Text] [Related]

  • 45. In vitro chronopharmacology of recombinant mouse IL-3, mouse GM-CSF, and human G-CSF on murine myeloid progenitor cells.
    Perpoint B, Le Bousse-Kerdilès C, Clay D, Smadja-Joffe F, Deprés-Brummer P, Laporte-simitsidis S, Jasmin C, Lévi F.
    Exp Hematol; 1995 Apr; 23(4):362-8. PubMed ID: 7534715
    [Abstract] [Full Text] [Related]

  • 46. Characterization and quantitation of primitive hematopoietic progenitor cells present in peripheral blood autografts.
    Tong J, Hoffman R, Siena S, Srour EF, Bregni M, Gianni AM.
    Exp Hematol; 1994 Sep; 22(10):1016-24. PubMed ID: 8088376
    [Abstract] [Full Text] [Related]

  • 47. [Effect of recombinant human growth factors: recombinant human interleukin-6, recombinant human granulocyte-macrophage colony-stimulating-factor and recombinant human erythropoietin on normal human hematopoietic progenitor cells].
    Wei DM, Wang LX, Chen PS.
    Zhonghua Nei Ke Za Zhi; 1994 May; 33(5):298-301. PubMed ID: 7835138
    [Abstract] [Full Text] [Related]

  • 48. Effects of various recombinant human hemopoietic growth factors (rhEpo, rhG-CSF, rhGM-CSF, rhIl-3) on the growth of peripheral blood progenitor cells (BFU-E, CFU-GM).
    Serke S, Huhn D.
    Blut; 1990 Jul; 61(1):25-9. PubMed ID: 1696841
    [Abstract] [Full Text] [Related]

  • 49. In vivo effects of recombinant human erythropoietin on circulating human hemopoietic progenitor cells.
    Ganser A, Bergmann M, Völkers B, Grützmacher P, Scigalla P, Hoelzer D.
    Exp Hematol; 1989 Jun; 17(5):433-5. PubMed ID: 2714423
    [Abstract] [Full Text] [Related]

  • 50. Effects of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo.
    Hino M, Miyazono K, Urabe A, Takaku F.
    Int J Cell Cloning; 1989 Jul; 7(4):257-63. PubMed ID: 2768843
    [Abstract] [Full Text] [Related]

  • 51. [Clinical efficacy analysis of recombinant human erythropoietin in the treatment of lower-risk myelodysplastic syndromes].
    Zhang H, Qin T, Xu Z, Fang L, Pan L, Hu N, Qu S, Zhang Y, Xiao Z.
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):18-23. PubMed ID: 24602726
    [Abstract] [Full Text] [Related]

  • 52. The in vitro effect of recombinant erythropoietin on cisdiamminodichloroplatinum-induced inhibition of murine erythroid stem cells.
    Gebbia V, Valenza R, Rausa L.
    Anticancer Res; 1990 Jan; 10(6):1779-82. PubMed ID: 2285259
    [Abstract] [Full Text] [Related]

  • 53. Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer.
    Weaver A, Chang J, Wrigley E, de Wynter E, Woll PJ, Lind M, Jenkins B, Gill C, Wilkinson PM, Pettengell R, Radford JA, Collins CD, Dexter TM, Testa NG, Crowther D.
    J Clin Oncol; 1998 Aug; 16(8):2601-12. PubMed ID: 9704709
    [Abstract] [Full Text] [Related]

  • 54. Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates.
    Andrews RG, Briddell RA, Knitter GH, Rowley SD, Appelbaum FR, McNiece IK.
    Blood; 1995 Jan 01; 85(1):15-20. PubMed ID: 7528562
    [Abstract] [Full Text] [Related]

  • 55. [In vivo effects on human neutrophils by administration of rhG-CSF and clinical significance].
    Okabe M, Saiki I, Nakane K, Miyazaki T.
    Rinsho Byori; 1992 Apr 01; 40(4):397-402. PubMed ID: 1375667
    [Abstract] [Full Text] [Related]

  • 56. Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers.
    Carlo-Stella C, Di Nicola M, Milani R, Guidetti A, Magni M, Milanesi M, Longoni P, Matteucci P, Formelli F, Ravagnani F, Corradini P, Gianni AM.
    Blood; 2004 May 01; 103(9):3287-95. PubMed ID: 14726397
    [Abstract] [Full Text] [Related]

  • 57. The combination of erythropoietin and granulocyte colony-stimulating factor increases the rate of haemopoietic recovery with clinical benefit after peripheral blood progenitor cell transplantation.
    Pierelli L, Scambia G, Menichella G, d'Onofrio G, Salerno G, Panici PB, Foddai ML, Vittori M, Lai M, Ciarli M, Puglia G, Mancuso S, Bizzi B.
    Br J Haematol; 1996 Feb 01; 92(2):287-94. PubMed ID: 8602987
    [Abstract] [Full Text] [Related]

  • 58. Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: results of a randomized comparison.
    Pierelli L, Perillo A, Greggi S, Salerno G, Panici PB, Menichella G, Fattorossi A, Leone G, Mancuso S, Scambia G.
    J Clin Oncol; 1999 Apr 01; 17(4):1288. PubMed ID: 10561191
    [Abstract] [Full Text] [Related]

  • 59. Uncaria tomentosa stimulates the proliferation of myeloid progenitor cells.
    Farias I, do Carmo Araújo M, Zimmermann ES, Dalmora SL, Benedetti AL, Alvarez-Silva M, Asbahr AC, Bertol G, Farias J, Schetinger MR.
    J Ethnopharmacol; 2011 Sep 01; 137(1):856-63. PubMed ID: 21771655
    [Abstract] [Full Text] [Related]

  • 60. Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin.
    Mantovani L, Lentini G, Hentschel B, Wickramanayake PD, Loeffler M, Diehl V, Tesch H.
    Br J Haematol; 2000 May 01; 109(2):367-75. PubMed ID: 10848827
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.